BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6589950)

  • 1. Plasma catecholamines in clinical studies of cardiovascular diseases.
    Goldstein DS
    Acta Physiol Scand Suppl; 1984; 527():39-41. PubMed ID: 6589950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man.
    Mueller HS; Ayres SM
    J Clin Invest; 1980 Feb; 65(2):338-46. PubMed ID: 7356683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Severely increased plasma catecholamine values in myocardial infarct with ventricular fibrillation; doubling during intensive care monitoring].
    Bertel O; Bühler FR; Steiner A; Baitsch G; Ritz R; Burkart F
    Schweiz Med Wochenschr; 1978 Nov; 108(44):1729-31. PubMed ID: 715411
    [No Abstract]   [Full Text] [Related]  

  • 5. The catecholamine-beta-adrenoreceptor-cAMP system and prediction of cardiovascular events in hypertension.
    Peng YX; Shan J; Qi XY; Zhang SJ; Ma SP; Wang N; Li JP; Xue H; Wu M
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):227-31. PubMed ID: 16487266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological and catecholamine response to sympathetic stimulation in turner syndrome.
    Zuckerman-Levin N; Zinder O; Greenberg A; Levin M; Jacob G; Hochberg Z
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):410-5. PubMed ID: 16584513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholamine sulfates and platelet phenolsulfotransferase activity in essential hypertension.
    Kuchel O; Buu NT; Hamet P; Larochelle P; Bourque M; Genest J
    J Lab Clin Med; 1984 Aug; 104(2):238-44. PubMed ID: 6589333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugated catecholamines in human plasma: where are they coming from?
    Cuche JL; Brochier P; Klioua N; Poirier MF; Cuche H; Benmiloud M; Loo H; Safar M
    J Lab Clin Med; 1990 Nov; 116(5):681-6. PubMed ID: 2230539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma norepinephrine and epinephrine levels in essential hypertension.
    Goldstein DS; Lake CR
    Fed Proc; 1984 Jan; 43(1):57-61. PubMed ID: 6690339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma catecholamines in patients with acute myocardial infarction and in cardiac arrest.
    Little RA; Frayn KN; Randall PE; Stoner HB; Yates DW; Laing GS; Kumar S; Banks JM
    Q J Med; 1985 Feb; 54(214):133-40. PubMed ID: 3885296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic activity in labile essential hypertension in young men. Part I. Plasma catecholamines after orthostatic and emotional stress test.
    Prikryl P; Rysánek K; Kvetnanský R; Kunovská V; Rechtoríková O; Dohnalová I
    Act Nerv Super (Praha); 1982 Mar; 24(1):29-30. PubMed ID: 7090719
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolism of myocardial catecholamines and plasma catecholamine levels in patients with chronic aortic regurgitation (author's transl)].
    Mäurer W; Ablasser A; Saggau W; Storch H; Hausen M; Helmus G; Kübler W
    Z Kardiol; 1981 Jul; 70(7):540-6. PubMed ID: 7269734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of plasma catecholamine increases during coronary artery bypass and valve procedures.
    Engelman RM; Haag B; Lemeshow S; Angelo A; Rousou JH
    J Thorac Cardiovasc Surg; 1983 Oct; 86(4):608-15. PubMed ID: 6604846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of sympathetic nervous system in hypertension and effects of cardiovascular drugs.
    Noll G; Wenzel RR; Binggeli C; Corti C; Lüscher TF
    Eur Heart J; 1998 Jun; 19 Suppl F():F32-8. PubMed ID: 9651733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma catecholamine levels in normal subjects and in patients with secondary hypertension.
    Lake CR; Chernow B; Goldstein DS; Glass DG; Coleman M; Ziegler MG
    Fed Proc; 1984 Jan; 43(1):52-6. PubMed ID: 6690338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diurnal rhythms and clinical events in coronary artery disease.
    Selwyn AP; Raby K; Vita JA; Ganz P; Yeung A
    Postgrad Med J; 1991; 67 Suppl 5():S44-7. PubMed ID: 1803340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma catecholamine levels in patients with symptomatic mitral valve prolapse.
    Pasternac A; Tubau JF; Puddu PE; Król RB; de Champlain J
    Am J Med; 1982 Dec; 73(6):783-90. PubMed ID: 6216809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symphathetic activity in labile essential hypertension in young men. Part II. Influence of exercise on plasma catecholamines.
    Rysánek K; Prikryl P; Kvetnanský R; Kunovská V; Rechtoríková O; Dohnalová I
    Act Nerv Super (Praha); 1982 Mar; 24(1):30-1. PubMed ID: 7090720
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is sympathetic hyperactivity a coronary risk factor?].
    Fogari R; Zoppi A
    Cardiologia; 1993 Dec; 38(12 Suppl 1):427-34. PubMed ID: 8020045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.